Amarin Corp Plc (AMRN)

[HDGabor]

Exactly: "They have an opportunity to ask us questions along the way. There's typically an opportunity for a face -- one face-to-face meeting and follow-up questions. And then there'll be a period after those occur that the FDA typically responds in roughly 30 days"

more

Q1 CC: "And then we'll probably end up meeting with him 30 days after we submit. And then after that, he should get back to us within another 30 days."

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM343101.pdf